BackDeciphera Pharmaceuticals Overview

Deciphera Pharmaceuticals Goodwill

Track Deciphera Pharmaceuticals's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Deciphera Pharmaceuticals Goodwill History

Loading

Deciphera Pharmaceuticals vs. peers: Goodwill Comparison

Loading

Deciphera Pharmaceuticals Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Deciphera Pharmaceuticals (DCPH) FAQ

Deciphera Pharmaceuticals (DCPH) currently reports a goodwill of $0 as of March 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore Deciphera Pharmaceuticals's goodwill history and peer comparisons.

Deciphera Pharmaceuticals's goodwill changed from $0 to $0 (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deciphera Pharmaceuticals reported $0 in goodwill as of March 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Deciphera Pharmaceuticals, and consider following DCPH for alerts when major investors trade the stock.

Deciphera Pharmaceuticals is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DCPH with unrelated industries.